InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Gabay Avraham. Officer active across 2 companies, notably Oramed Pharmaceuticals INC.. Aggregated, 8 disclosures have been recorded. History available since 11 February 2025. The latest transaction was filed on 20 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Gabay Avraham is Chief Financial Officer at Oramed Pharmaceuticals INC. (XNAS). He has 7 filings in total, and in the sampled recent filings from 2024-06-21 to 2026-03-18, the buy and sell amounts are 0 EUR each, with the transaction nature indicated as Attribution.